|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||
| 化学式 | C18H12O3 |
||||||||||
| 分子量 | 276.29 | CAS No. | 568-73-0 | ||||||||
| Solubility (25°C)* | 体外 | DMSO | Insoluble | ||||||||
| Water | Insoluble | ||||||||||
| Ethanol | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | Tanshinone I, an active principle isolated from Salvia miltiorrhiza (Danshen), is structurally similar to tanshinone IIA and may possess similar cytotoxic effects on tumor cells. |
|---|---|
| in vitro | Tanshinone I, an active principle isolated from Salvia miltiorrhiza (Danshen), is structurally similar to tanshinone IIA and may possess similar cytotoxic effects on tumor cells. This compound inhibits PGE2 formation from LPS-induced RAW macrophages (IC50 = 38 μM). However, this compound does not affect COX-2 activity or COX-2 expression. It is an inhibitor of type IIA human recombinant phospholipase A2 (PLA2) with IC50 of 11 μM. [1] In preliminary data, this chemical possesses the strongest inhibitory effect on tumor necrosis factor-α (TNF-α)-induced adhesion molecules. [2] |
|

Data from [Data independently produced by , , Oncotarget, 2015, 6(18):16031-42.]

Data from [Data independently produced by , , Biochem Pharmacol, 2018, 154:255-264]
| Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma [ Int J Oncol, 2023, 63(1)76] | PubMed: 37203411 |
| Tanshinone I inhibits metastasis of cervical cancer cells by inducing BNIP3/NIX-mediated mitophagy and reprogramming mitochondrial metabolism [ Phytomedicine, 2022, 98:153958] | PubMed: 35124382 |
| Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α [ Drug Des Devel Ther, 2022, 16:3197-3213] | PubMed: 36158238 |
| Tanshinone I and simvastatin inhibit melanoma tumour cell growth by regulating poly (ADP ribose) polymerase 1 expression [ Mol Med Rep, 2021, 23(1)40] | PubMed: 33179075 |
| An antiviral drug screening system for enterovirus 71 based on an improved plaque assay: A potential high-throughput method [ J Med Virol, 2019, 91(8):1440-1447] | PubMed: 30900754 |
| A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza. [ Int Immunopharmacol, 2019, 10.1016/j.intimp.2019.106040] | PubMed: 31818704 |
| Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity [Qin J Biomed Pharmacother, 2018, 105:758-765] | PubMed: 29909343 |
| New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis [Tian QT Biochem Pharmacol, 2018, 154:255-264] | PubMed: 29753750 |
| Tanshinone I alleviates motor and cognitive impairments via suppressing oxidative stress in the neonatal rats after hypoxic-ischemic brain damage. [ Mol Brain, 2017, 10(1):52] | PubMed: 29137683 |
| Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells [Wang Y, et al. Oncotarget, 2015, 6(18):16031-42] | PubMed: 26202747 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。